VALERIO, CRISTIANA
 Distribuzione geografica
Continente #
EU - Europa 4.304
NA - Nord America 2.031
AS - Asia 1.453
SA - Sud America 187
AF - Africa 55
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.033
Nazione #
US - Stati Uniti d'America 2.016
IT - Italia 1.712
GB - Regno Unito 755
CN - Cina 509
FR - Francia 439
SG - Singapore 424
DE - Germania 410
SE - Svezia 215
UA - Ucraina 188
RU - Federazione Russa 157
NL - Olanda 156
HK - Hong Kong 138
IN - India 131
BR - Brasile 123
TR - Turchia 89
KR - Corea 76
EU - Europa 68
PL - Polonia 65
IE - Irlanda 64
FI - Finlandia 41
CI - Costa d'Avorio 39
CO - Colombia 39
GR - Grecia 35
BE - Belgio 22
VN - Vietnam 14
JP - Giappone 11
AR - Argentina 10
ID - Indonesia 10
CA - Canada 7
CH - Svizzera 7
HU - Ungheria 6
NP - Nepal 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
ES - Italia 5
IQ - Iraq 5
MX - Messico 5
MY - Malesia 5
ZA - Sudafrica 5
BD - Bangladesh 4
DK - Danimarca 4
JO - Giordania 4
AT - Austria 3
EC - Ecuador 3
EG - Egitto 3
MA - Marocco 3
PT - Portogallo 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
KZ - Kazakistan 2
PH - Filippine 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
ZW - Zimbabwe 1
Totale 8.101
Città #
Southend 601
Chandler 266
Singapore 241
Milan 210
Jacksonville 172
Ashburn 155
Beijing 134
Hong Kong 134
Rome 110
Houston 86
Princeton 79
Dallas 77
Wilmington 66
Dublin 64
Redmond 63
Bengaluru 60
Santa Clara 60
Seattle 60
Warsaw 60
Serra 57
Los Angeles 55
Mountain View 53
Council Bluffs 50
Margão 49
Nanjing 46
Ann Arbor 42
Dearborn 42
Naples 41
Woodbridge 41
Abidjan 39
Andover 38
Bogotá 38
Buffalo 37
Phoenix 37
Sakarya 37
Athens 35
Hefei 33
Pisa 30
Florence 28
Palermo 28
Somerville 28
Frankfurt am Main 27
Boardman 26
Shanghai 26
Des Moines 23
Columbus 22
Reggio Calabria 22
The Dalles 22
Turin 21
Cangzhou 19
Nürnberg 19
Scranton 19
Kiez 17
Brussels 16
Guangzhou 16
Falls Church 15
Genoa 15
Bari 14
Fremont 14
Fuzhou 14
Napoli 14
Pescara 14
Verona 14
São Paulo 13
Nanchang 12
Bologna 11
Moscow 11
Treviso 10
Auburn Hills 9
Berlin 9
Fairfield 9
London 9
Nuremberg 9
Brescia 8
Cagliari 8
Catanzaro 8
Hanoi 8
Redwood City 8
Bergamo 7
Bitonto 7
Bühl 7
Mumbai 7
Nova Milanese 7
Padova 7
Roubaix 7
Shenyang 7
Brembate di Sopra 6
Budapest 6
Chicago 6
Jiaxing 6
Monza 6
Pavia 6
Brooklyn 5
Cosenza 5
Desenzano del Garda 5
Hebei 5
Kunming 5
Macerata 5
Messina 5
New York 5
Totale 4.265
Nome #
L'indicizzazione della massa ventricolare sinistra (MVS) per la superficie corporea sottostima la prevalenza di ipertrofia ventricolare sinistra (IVS) negli ipertesi essenziali 1.778
Pressione arteriosa ambulatoria, danno d'organo e dimensioni dell'atrio sinistro negli ipertesi essenziali non trattati 277
Retinal microvascular changes and target organ damage in untreated essential hypertensives 275
Prevalence and correlates of left atrial enlargement in essential hypertension : role of ventricular geometry and the metabolic syndrome 240
Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension 229
Short-term reproducibility of non-dipping pattern in type 2 diabetic hypertensive patients 219
Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension 214
Prevalence and correlates of left atrial enlargement in essential hypertension : role of ventricular geometry and the metabolic syndrome : the Evaluation of Target Organ Damage in Hypertension study 213
Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) Study 213
Carotid atherosclerosis and cardiovascular risk stratification : role and cost-effectiveness of echo-doppler examination in untreated essential hypertensives 211
Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients 204
Left ventricular hypertrophy and cardiovascular risk stratification : impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives 204
Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients 198
Awareness of hypertension guidelines in primary care: results of a regionwide urvey in Italy 197
Prevalence and correlates of aortic root dilatation in patients with essential hypertension : relationship with cardiac and extracardiac target organ damage 195
Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension : comparison with the 1999 WHO/ISH guidelines criteria 192
Left ventricular hypertrophy and cardiovascular risk stratification : impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives 190
Age and target organ damage in essential hypertension : role of the metabolic syndrome 187
Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients 185
Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study 179
Short-term reproducibility of non-dipping pattern in type 2 diabetic hypertensive patients 178
Left ventricular hypertrophy and cardiovascular risk stratification : impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives 174
Age and target organ damage in essential hypertension : role of the metabolic syndrome 172
Metabolic syndrome and target organ damage in untreated essential hypertensives 171
Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome? 171
Carotid atherosclerosis and cardiovascular risk stratification : role and cost-effectiveness of echo-doppler examination in untreated esseential hypertensives 166
Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals 164
Home blood pressure measurement and its relationship with blood pressure control in a large selected hypertensive population 163
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 151
Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia 150
How reliable is isolated clinic hypertension defined by a single ambulatory blood pressure monitoring? 147
Prevalence and clinical correlates of right ventricular hypertrophy in essential hyperyension 142
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to ibese hypertensive patients? 142
Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients 139
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients : impact of sex and age 135
Cardiovascular target organ damage in essential hypertensive with or without reproducible nocturnal fall in blood pressure 128
Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension : a prospective observation study 107
Totale 8.400
Categoria #
all - tutte 18.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021474 0 0 0 0 63 40 65 11 75 23 168 29
2021/2022540 30 11 16 32 37 20 63 54 75 53 39 110
2022/20231.084 89 114 84 165 126 179 55 58 133 25 38 18
2023/2024591 25 36 20 29 114 31 45 85 30 43 58 75
2024/20251.372 42 119 34 183 133 64 100 121 76 110 126 264
2025/2026761 264 118 209 132 38 0 0 0 0 0 0 0
Totale 8.400